The clinical symptoms of Parkinson's disease.

Cited by (1,402)

Items 201–300 of 1,402

1. Physiological and pathological functions of LRRK2: implications from substrate proteins
   Miho Araki, Genta Ito, Taisuke Tomita · 2018 · Neuronal Signaling
2. Why would Parkinson’s disease lead to sudden changes in creativity, motivation, or style with visual art?: A review of case evidence and new neurobiological, contextual, and genetic hypotheses
   Jon O. Lauring, Tomohiro Ishizu, Hana H. Kutlikova, Felix Dörflinger, Steven Haugbøl, Helmut Leder, Ron C. Kupers, Matthew J. Pelowski · 2019 · Neuroscience & Biobehavioral Reviews
3. PERK-Mediated eIF2α Phosphorylation Contributes to The Protection of Dopaminergic Neurons from Chronic Heat Stress in Drosophila
   Rosalie Elvira, Sun Joo Cha, Gyeong-Mu Noh, Kiyoung Kim, Jaeseok Han · 2020 · International Journal of Molecular Sciences
4. RIPK1 inhibitor ameliorates the MPP+/MPTP-induced Parkinson’s disease through the ASK1/JNK signalling pathway
   Jing Liu, Huizheng Hu, Binyan Wu · 2021 · Brain Research
5. Novel insights into the role of circular RNAs in Parkinson disease: An emerging renaissance in the management of neurodegenerative diseases
   Zahra Dorostgou, Negar Yadegar, Zeynab Dorostgou, Fariborz Khorvash, Omid Vakili · 2022 · Journal of Neuroscience Research
6. Wearable gait monitoring for diagnosis of neurodegenerative diseases
   Huan Zhao, Ruixue Wang, Dexin Qi, Junxiao Xie, Junyi Cao, Wei‐Hsin Liao · 2022 · Measurement
7. Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies
   Mariana Veiga, João Azevedo‐Silva, João Carlos Fernandes · 2023 · Pharmaceuticals
8. Exploring public perceptions and awareness of Parkinson’s disease: A scoping review
   Sophie Crooks, Gillian Carter, Christine Brown Wilson, Lisa Wynne, Patrick Stark, Michail Doumas, Matthew W. M. Rodger, Emma O’Shea, Gary Mitchell · 2023 · PLoS ONE
9. The VEGFs/VEGFRs system in Alzheimer’s and Parkinson’s diseases: Pathophysiological roles and therapeutic implications
   Claudia Ceci, Pedro Miguel Lacal, Maria Luisa Barbaccia, Nicola Biagio Mercuri, Grazia Graziani, Ada Ledonne · 2024 · Pharmacological Research
10. Oxidative Stress in Neurodegenerative Disorders: A Key Driver in Impairing Skeletal Muscle Health
    Serena Castelli, Emily Carinci, Sara Baldelli · 2025 · International Journal of Molecular Sciences
11. RETRACTED: A computational approach to identify blood cell-expressed Parkinson's disease biomarkers that are coordinately expressed in brain tissue
    Mohammad Ali Moni, Humayan Kabir Rana, Md. Babul Islam, Mohammad Boshir Ahmed, Haoming Xu, Md. Al Mehedi Hasan, Yiming Lei, Julian M.W. Quinn · 2019 · Computers in Biology and Medicine · Retracted
12. Therapeutic Potential of Repeated Intravenous Transplantation of Human Adipose-Derived Stem Cells in Subchronic MPTP-Induced Parkinson’s Disease Mouse Model
    Hyun‐Jun Park, Keun‐A Chang · 2020 · International Journal of Molecular Sciences
13. A dual-branch model for diagnosis of Parkinson’s disease based on the independent and joint features of the left and right gait
    Xu Liu, Wang Li, Zheng Liu, Feixiang Du, Qiang Zou · 2021 · Applied Intelligence
14. RETRACTED ARTICLE: Non-invasive vagus nerve stimulation improves clinical and molecular biomarkers of Parkinson’s disease in patients with freezing of gait
    Banashree Mondal, Supriyo Choudhury, Rebecca Banerjee, Akash Roy, Koustav Chatterjee, Purba Basu, Ravi Singh, Saptak Halder, Shantanu Shubham, Stuart N. Baker et al. · 2021 · npj Parkinson s Disease · Retracted
15. A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson’s disease
    Camilla Christina Pedersen, Johannes Lange, Marthe Gurine Gunnarsdatter Førland, Angus D. Macleod, Guido Werner Alves, Jodi Maple‐Grødem · 2021 · npj Parkinson s Disease
16. An optimized RNN-LSTM approach for parkinson’s disease early detection using speech features
    Hadeel Ahmed Abd El Aal, Shereen A. Taie, Nashwa El-Bendary · 2021 · Bulletin of Electrical Engineering and Informatics
17. Chalcones as Potential Ligands for the Treatment of Parkinson’s Disease
    Ewelina Królicka, Katarzyna Kieć‐Kononowicz, Dorota Łażewska · 2022 · Pharmaceuticals
18. Global Alterations of Whole Brain Structural Connectome in Parkinson’s Disease: A Meta-analysis
    Chao Zuo, Xueling Suo, Huan Lan, Nanfang Pan, Song Wang, Graham John Kemp, Qiyong Gong · 2022 · Neuropsychology Review
19. Learning acoustic features to detect Parkinson’s disease
    Kebin Wu, David D. Zhang, Guangming Lu, Zhenhua Guo · 2018 · Neurocomputing
20. Recent Progress of Nanomedicine in the Treatment of Central Nervous System Diseases
    Leyan Feng, Heping Wang, Xue Xue · 2020 · Advanced Therapeutics
21. The relationship between Parkinson’s disease symptoms and caregiver quality of life.
    Richard S. Henry, Sarah K. Lageman, Paul B. Perrin · 2020 · Rehabilitation Psychology
22. Arbutin effectively ameliorates the symptoms of Parkinson’s disease: the role of adenosine receptors and cyclic adenosine monophosphate
    Jie Zhao, Manish Kumar, Jeevan Sharma, Zhihai Yuan · 2021 · Neural Regeneration Research
23. Effects of tai chi and Qigong on cognition in neurological disorders: A systematic review and meta-analysis
    Yuxin Wang, Qi Zhang, Fei Yue Li, Qi Li, Yi Jin · 2022 · Geriatric Nursing
24. Protein and Gene Delivery Systems for Neurodegenerative Disorders: Where Do We Stand Today?
    Panoraia I. Siafaka, Mehmet Evren Okur, Pelin Dilsiz, Emre Şefik Çağlar, Emre Özgenç, Evren Gündoğdu, Rabia Edibe Parlar Köprülü, Ioannis D. Karantas, Neslihan Üstündağ Okur · 2022 · Pharmaceutics
25. Assessment of Parkinson’s Disease Severity From Videos Using Deep Architectures
    Zhao Yin, Victor Jacobus Geraedts, Ziqi Wang, Maria Fiorella Contarino, Hamdi Dibeklioğlu, Jan C. van Gemert · 2021 · IEEE Journal of Biomedical and Health Informatics
26. Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers
    Mathieu Herman, Grace W. Randall, Julia L. Spiegel, Delphina J. Maldonado, Sabrina Simoes · 2024 · Philosophical Transactions of the Royal Society B Biological Sciences
27. Beta2-Adrenoceptor Agonists in Parkinson’s Disease and Other Synucleinopathies
    Luca Magistrelli, Cristoforo Comi · 2019 · Journal of Neuroimmune Pharmacology
28. Discovery of N -(1-(3-fluorobenzoyl)-1 H -indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B
    Ahmed Elkamhawy, Sora Paik, Hyeon Jeong Kim, Jong Hyun Park, Ashwini M. Londhe, Kyeong Lee, Ae Nim Pae, Ki Duk Park, Eun Joo Roh · 2020 · Journal of Enzyme Inhibition and Medicinal Chemistry
29. Development and optimization of halogenated vinyl sulfones as Nrf2 activators for the treatment of Parkinson’s disease
    Jin‐Sung Choi, Siwon Kim, Jong Seok Yoo, Hyeon Jeong Kim, Hyeon Ji Kim, Byung Eun Kim, Elijah Hwejin Lee, Yong Sup Lee, Jong‐Hyun Park, Ki Duk Park · 2020 · European Journal of Medicinal Chemistry
30. Identification of the Raman Salivary Fingerprint of Parkinson’s Disease Through the Spectroscopic– Computational Combinatory Approach
    Cristiano Carlomagno, Dario Bertazioli, Alice Gualerzi, Silvia Picciolini, Michele Andrico, Francesca Rodà, Mario Meloni, Paolo Innocente Banfi, Federico Verde, Nicola Ticozzi et al. · 2021 · Frontiers in Neuroscience
31. Good bacteria, oxidative stress and neurological disorders: Possible therapeutical considerations
    Masoud Soheili, Azam Alinaghipour, Mahmoud Salami · 2022 · Life Sciences
32. Meta-analysis of randomized controlled trials of the effects of probiotics in Parkinson's disease
    Chuanqi Chu, Leilei Yu, Yiwen Helen Li, Hang Guo, Qixiao Zhai, Wei Chen, Fengwei Tian · 2023 · Food & Function
33. Microbiota, Tryptophan and Aryl Hydrocarbon Receptors as the Target Triad in Parkinson’s Disease—A Narrative Review
    Paulina Iwaniak, Maja Owe-Larsson, Ewa M. Urbańska · 2024 · International Journal of Molecular Sciences
34. Non-pharmacological therapies for treating non-motor symptoms in patients with Parkinson’s disease: a systematic review and meta-analysis
    Yu Zhang, Shuang Liu, Ke Xu, Yan Zhou, Yiwei Shen, Zhengnan Liu, Yan Bai, Shun Wang · 2024 · Frontiers in Aging Neuroscience
35. Association of Dopamine Beta-Hydroxylase Polymorphisms with Alzheimer’s Disease, Parkinson’s Disease and Schizophrenia: Evidence Based on Currently Available Loci
    Siqi Tang, Bin Yao, Na Li, Shuhuang Lin, Zunnan Huang · 2018 · Cellular Physiology and Biochemistry
36. Switching on Endogenous Metal Binding Proteins in Parkinson’s Disease
    Fleur Alice McLeary, Alexandre Nay Rcom-H'cheo-Gauthier, Michael Goulding, Rowan A. W. Radford, Yuho Okita, Peter Faller, Roger S. Chung, Dean L. Pountney · 2019 · Cells
37. Does perturbation in the mitochondrial protein folding pave the way for neurodegeneration diseases?
    Ting Ji, Xiaolu Zhang, Zhenlong Xin, Baoping Xu, Zhenxiao Jin, Jiawei Wu, Wei Hu, Yang Yang · 2019 · Ageing Research Reviews
38. Therapeutic antisense oligonucleotides for movement disorders
    Epaminondas Doxakis · 2020 · Medicinal Research Reviews
39. Effects of home‐based exercise on motor, non‐motor symptoms and health‐related quality of life in Parkinsonʼs disease patients: A randomized controlled trial
    Pei‐Ling Wu, Megan Lee, Shey‐Lin Wu, Hsueh‐Hou Ho, Ming‐Hong Chang, Hsia‐Sui Lin, Tzu‐Ting Huang · 2021 · Japan Journal of Nursing Science
40. Hopf bifurcation analysis for Parkinson oscillation with heterogeneous delays: A theoretical derivation and simulation analysis
    Zhizhi Wang, Bing Hu, Luyao Zhu · 2022 · Communications in Nonlinear Science and Numerical Simulation
41. The Potential Role of Voltage‐Dependent Anion Channel in the Treatment of Parkinson’s Disease
    Yajie He, Wenjun Wang, Ting Yang, Elizabeth Rosalind Thomas, Rongyang Dai, Xiang Li · 2022 · Oxidative Medicine and Cellular Longevity
42. Neuroprotective and Anti-Inflammatory Effects of Pioglitazone on Parkinson's Disease: A Comprehensive Narrative Review of Clinical and Experimental Findings
    Mohammad Yasin Zamanian, Ermias Mergia Terefe, Niloofar Taheri, Małgorzata Kujawska, Yekta Jahedi Tork, Walid Kamal Abdelbasset, Shehla Shoukat, Maria Jade Catalan Opulencia, Mahsa Heidari, ‬‬Samira Alesaeidi · 2022 · CNS & Neurological Disorders - Drug Targets
43. A functionalized hydroxydopamine quinone links thiol modification to neuronal cell death
    Ali Farzam, Karan L. Chohan, Miroslava Strmiskova, Sarah J. Hewitt, David S. Park, John Paul Pezacki, Dennis Özcelik · 2019 · Redox Biology
44. Effects of Nordic walking in people with Parkinson's disease: A systematic review and meta‐analysis
    Jorge Salse‐Batán, Miguel Adriano Sánchez-Lastra, David Suárez-Iglesias, Silvia Varela, Carlos Ayán Pérez · 2022 · Health & Social Care in the Community
45. Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy
    Patrycja Maszka, Magdalena Kwaśniak-Butowska, Dominik Cysewski, Jarosław W. Sławek, Ryszard Tomasz Smolenski, Marta Tomczyk · 2023 · Metabolites
46. Transcriptomics of Human Brain Tissue in Parkinson’s Disease: a Comparison of Bulk and Single-cell RNA Sequencing
    Michael R. Fiorini, Allison Ann Dilliott, Rhalena A. Thomas, Sali M.K. Farhan · 2024 · Molecular Neurobiology
47. Insomnia in Parkinson’s Disease: Causes, Consequences, and Therapeutic Approaches
    Xiaoyu Duan, Hanshu Liu, Xinyu Hu, Qinwei Yu, Guiying Kuang, Long Liu, Shurui Zhang, Xinyi Wang, Jingwen Li, Danfang Yu et al. · 2024 · Molecular Neurobiology
48. Enfermedad de Parkinson: fisiopatología, diagnóstico y tratamiento
    Universidad Tecnológica de Pereira, Daniel S Marín, Hans Carmona Villada, Universidad Tecnológica de Pereira, Melissa Ibarra, Grupo de Investigación “Applied Neuroscience”, Neurocentro. Risaralda, Colombia, Manuela Gámez-Cárdenas, Universidad Tecnológica de Pereira · 2018 · Salud UIS
49. LncRNA SNHG1 promotes neuronal injury in Parkinson’s disease cell model by miR-181a-5p/CXCL12 axis
    Hui Wang, Xiaopeng Wang, Yiying Zhang · 2021 · Journal of Molecular Histology
50. EEG, MEG and neuromodulatory approaches to explore cognition: Current status and future directions
    Carolina Beppi, Inês R. Violante, Gregory Scott, Stefano Sandrone · 2021 · Brain and Cognition
51. Alterations of Erythrocytic Phosphorylated Alpha-Synuclein in Different Subtypes and Stages of Parkinson's Disease
    Xuying Li, Wei Li, Xin Li, Xuran Li, Linjuan Sun, Weiwei Yang, Yanning Cai, Zhigang Chen, Jun Wu, Chaodong Wang et al. · 2021 · Frontiers in Aging Neuroscience
52. Corynoxine B derivative CB6 prevents Parkinsonian toxicity in mice by inducing PIK3C3 complex-dependent autophagy
    Zhou Zhu, Liang‐Feng Liu, Cheng-Fu Su, Jia Liu, Benjamin Chun‐Kit Tong, Ashok Iyaswamy, Senthilkumar Krishnamoorthi, Sravan Gopalkrishnashetty Sreenivasmurthy, Xin-jie Guan, Yuxuan Kan et al. · 2022 · Acta Pharmacologica Sinica
53. Worse Sleep Quality Aggravates the Motor and Non-Motor Symptoms in Parkinson's Disease
    Qu Yi, Chen Yu-Peng, Li Jiang-Ting, Li Jing-Yi, Qin Qi-Xiong, Wang Dan-Lei, Zhao Jing-Wei, Mao Zhi-Juan, Yong-jie Xiong, Zhe Min et al. · 2022 · Frontiers in Aging Neuroscience
54. A Comparative Study of Time Frequency Representation Techniques for Freeze of Gait Detection and Prediction
    Ashfaque Mostafa, Tahjid, Soltaninejad, Sara, McIsaac, Tara L., Cheng, Irene · 2021 · Sensors
55. Detection of hypomimia in patients with Parkinson’s disease via smile videos
    Ge Su, Bo Lin, Jianwei Yin, Wei Feng Luo, Renjun Xu, Jie Xu, Kexiong Dong · 2021 · Annals of Translational Medicine
56. A minimally invasive neurostimulation method for controlling abnormal synchronisation in the neuronal activity
    Malbor Asllani, P. Expert, T. Carletti · 2017 · PLoS Comput. Biol.
57. Characterization of the intestinal microbiota during Citrobacter rodentium infection in a mouse model of infection-triggered Parkinson’s disease
    Tyler Cannon, Anshul Sinha, Louis‐Éric Trudeau, Corinne F. Maurice, Samantha Gruenheid · 2020 · Gut Microbes
58. ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson’s Disease
    Siokas, Vasileios, Aloizou, Athina-Maria, Tsouris, Zisis, Liampas, Ioannis, Liakos, Panagiotis, Calina, Daniela, Docea, Anca Oana, Tsatsakis, Aristidis, Bogdanos, Dimitrios P., Hadjigeorgiou, Georgios M. et al. · 2021 · Journal of Clinical Medicine
59. Combined Ubisol-Q10 and Ashwagandha Root Extract Target Multiple Biochemical Mechanisms and Reduces Neurodegeneration in a Paraquat-Induced Rat Model of Parkinson’s Disease
    Caleb Vegh, Darcy Wear, Iva Okaj, Rachel Huggard, Lauren Culmone, Şeyma Eren, Jerome S. Cohen, Arun K. Rishi, Siyaram Pandey · 2021 · Antioxidants
60. Synergistic Photothermal and Chemical Therapy by Smart Dual‐Functional Graphdiyne Nanosheets for Treatment of Parkinson's Disease
    Tianzhong Li, Yao Z. Liu, Wenli Bao, Jingshan Luo, Lingfeng Gao, Xiaojia Chen, Shengpeng Wang, Jiangtian Yu, Yanqi Ge, Bin Zhang et al. · 2021 · Advanced Therapeutics
61. Detection of Freezing of Gait Using Unsupervised Convolutional Denoising Autoencoder
    Mohd Halim Mohd Noor, Amril Nazir, Mohd Nadhir Ab Wahab, Jodene Ooi Yen Ling · 2021 · IEEE Access
62. A Computerized Analysis with Machine Learning Techniques for the Diagnosis of Parkinson’s Disease: Past Studies and Future Perspectives
    Arti Rana, Ankur Dumka, Rajesh Singh, Manoj Kumar Panda, Neeraj Priyadarshi · 2022 · Diagnostics
63. Protective mechanism of Paeonol on central nervous system
    Rui Wu, Yanfang Liu, Fang Zhang, Shu Dai, Xinyan Xue, Cheng Peng, Yan Li, Yunxia Li · 2023 · Phytotherapy Research
64. A Visibility Graph Approach for Multi-Stage Classification of Parkinson’s Disease Using Multimodal Data
    K. Deepa Raj, G. Jyothish Lal, E. A. Gopalakrishnan, V. Sowmya, Juan Rafael Orozco‐Arroyave · 2024 · IEEE Access
65. Extraction of large-scale structural covariance networks from grey matter volume for Parkinson’s disease classification
    Pei‐Lin Lee, Kun‐Hsien Chou, Cheng-Hsien Lu, Hsiu-Ling Chen, Nai‐Wen Tsai, Ai‐Ling Hsu, Meng‐Hsiang Chen, Wei‐Che Lin, Ching‐Po Lin · 2018 · European Radiology
66. Microbial Tyrosinases: A Novel Enzyme, Structural Features, and Applications
    Pragati Agarwal, Mukta Singh, Jyoti Prakash Singh · 2018 · Elsevier eBooks
67. New markers in Parkinson's disease
    Anastasia M. Bougea · 2020 · Advances in clinical chemistry
68. Neuropathology of Kynurenine Pathway of Tryptophan Metabolism
    Abdulkarim Tutakhail, L. Boulet, Sarah Khabil, Q. Nazari, H. Hamid, F. Coudoré · 2020 · Current Pharmacology Reports
69. DJ-1 (Park7) affects the gut microbiome, metabolites and the development of innate lymphoid cells (ILCs)
    Yogesh Singh, Christoph Trautwein, Achal Dhariwal, Madhuri S. Salker, Md Alauddin, Laimdota Zizmare, Lisann Pelzl, Martina Feger, Jakob Admard, Nicolas Casadei et al. · 2020 · Scientific Reports
70. Effects of Ten Different Exercise Interventions on Motor Function in Parkinson’s Disease Patients—A Network Meta-Analysis of Randomized Controlled Trials
    Zikang Hao, Xiaodan Zhang, Ping Chen · 2022 · Brain Sciences
71. Intermittent fasting protects the nigral dopaminergic neurons from MPTP-mediated dopaminergic neuronal injury in mice
    Uttam Ojha, Shristi Khanal, Pil‐Hoon Park, Jin Tae Hong, Dong‐Young Choi · 2022 · The Journal of Nutritional Biochemistry
72. Rabs, Membrane Dynamics, and Parkinson's Disease
    Bor Luen Tang · 2016 · Journal of Cellular Physiology
73. Impact of non-motor fluctuations on QOL in patients with Parkinson’s disease
    Asako Kakimoto, Miki Kawazoe, Kanako Kurihara, Takayasu Mishima, Yoshio Tsuboi · 2023 · Frontiers in Neurology
74. Evaluating Motor Symptoms in Parkinson’s Disease Through Wearable Sensors: A Systematic Review of Digital Biomarkers
    Carlos Polvorinos-Fernández, Luis Sigcha, Luigi Borzì, Gabriella Olmo, C. Asensio, Juan Manuel López, Guillermo de Arcas, Ignacio Pavón · 2024 · Applied Sciences
75. The Potent PDE10A Inhibitor MP-10 (PF-2545920) Suppresses Microglial Activation in LPS-Induced Neuroinflammation and MPTP-Induced Parkinson’s Disease Mouse Models
    Do‐Yeon Kim, Jin‐Sun Park, Yea‐Hyun Leem, Jung-Eun Park, Hee-Sun Kim · 2020 · Journal of Neuroimmune Pharmacology
76. Identification of Terpenoids From Abrus precatorius Against Parkinson’s Disease Proteins Using In Silico Approach
    Damilola Alex Omoboyowa, Toheeb Adewale Balogun, Oluwaseun Motunrayo Omomule · 2021 · Bioinformatics and Biology Insights
77. Effects of bee venom and dopamine-loaded nanoparticles on reserpine-induced Parkinson’s disease rat model
    Omar Abdel-hamed Ahmed-Farid, Mohamed Taha, Rofanda M. Bakeer · 2021 · Scientific Reports
78. Transcriptomics and Proteomics Approach for the Identification of Altered Blood microRNAs and Plasma Proteins in Parkinson’s Disease
    Sanjeev Kumar Yadav, Abhishek Jauhari, Nishant Singh, Anuj Kumar Pandey, Sana Sarkar, Shweta Pandey, Ravindra Kumar Garg, Devendra Parmar, Sanjay Yadav · 2023 · Cellular and Molecular Neurobiology
79. Mechanistic Insight into the Binding Profile of DCVJ and α-Synuclein Fibril Revealed by Multiscale Simulations
    Guanglin Kuang, N. Arul Murugan, Hans Ågren · 2018 · ACS Chemical Neuroscience
80. A coordinate attention enhanced swin transformer for handwriting recognition of Parkinson's disease
    Nana Wang, Xuesen Niu, Yiyang Yuan, Yunze Sun, Ran Li, Guoliang You, Aite Zhao · 2023 · IET Image Processing
81. Cerebellar functional abnormalities in early stage drug-naïve and medicated Parkinson’s disease
    Shuai Xu, Xinwei He, Rong Zhao, Wei Chen, Zhaoxia Qin, Jilei Zhang, Shiyu Ban, Gefei Li, Yan-Hui Shi, Yue Hu et al. · 2019 · Journal of Neurology
82. Tai Chi versus routine exercise in patients with early- or mild-stage Parkinson's disease: a retrospective cohort analysis
    Quanhao Li, Jinmei Liu, Fei Dai, Fengling Dai · 2020 · Brazilian Journal of Medical and Biological Research
83. Single arm prospective multicenter case series on the use of burst stimulation to improve pain and motor symptoms in Parkinson’s disease
    Krishnan V Chakravarthy, Rahul Chaturvedi, Takashi Agari, Hirokazu Iwamuro, Rajiv D Reddy, Ayano Matsui · 2020 · Bioelectronic Medicine
84. Limonoids from the Fresh Young Leaves and Buds of Toona sinensis and Their Potential Neuroprotective Effects
    Yan-Hui Fu, Yutong Xie, Jiaming Guo · 2020 · Journal of Agricultural and Food Chemistry
85. Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson’s Disease
    Dominika Fričová, Jana Harsányiová, Alzbeta Kralova Trancikova · 2020 · International Journal of Molecular Sciences
86. Laterality in Parkinson’s disease: A neuropsychological review
    Marilyn J. Steinbach, Ransom W. Campbell, Benjamin B. DeVore, David W. Harrison · 2021 · Applied Neuropsychology Adult
87. Healthcare management applications based on triboelectric nanogenerators
    Irfan Shabbir, Najaf Rubab, Tae Whan Kim, Sang‐Woo Kim · 2021 · APL Materials
88. Dietary patterns affect Parkinson's disease via the microbiota-gut-brain axis
    Chuanqi Chu, Leilei Yu, Wei Chen, Fengwei Tian, Qixiao Zhai · 2021 · Trends in Food Science & Technology
89. Circular RNA circTLK1 regulates dopaminergic neuron injury during Parkinson‘s disease by targeting miR-26a-5p/DAPK1
    Wangsheng Chen, Changlong Hou, Yibin Wang, Lan Hong, Fei Wang, Jianhua Zhang · 2022 · Neuroscience Letters
90. New Insights into the Gut Microbiota in Neurodegenerative Diseases from the Perspective of Redox Homeostasis
    Yu Wang, Zhe Zhang, Bowen Li, Bo He, Lei Li, Edouard Collins Nice, Wei Zhang, Jia Feng Xu · 2022 · Antioxidants
91. Immune Modulatory Effects of Ketogenic Diet in Different Disease Conditions
    Shivani Srivastava, Vishakha Anand Pawar, Anuradha Tyagi, Kanti Sharma, Vinay Kumar, Surendra Kumar Shukla · 2022 · Immuno
92. Mass Spectrometric Analysis of Urinary N-Glycosylation Changes in Patients with Parkinson’s Disease
    Mingming Xu, Hong Jin, Wei Ge, Lingbo Zhao, Zhaoliang Liu, Zeyu Guo, Zhen Wu, Jing Chen, Chengjie Mao, Xumin Zhang et al. · 2023 · ACS Chemical Neuroscience
93. Updates on the Physiopathology of Group I Metabotropic Glutamate Receptors (mGluRI)-Dependent Long-Term Depression
    Dalila Mango, Ada Ledonne · 2023 · Cells
94. Astrocytes and Alpha-Synuclein: Friend or Foe?
    Hakan Ozoran, Rahul Srinivasan · 2023 · Journal of Parkinson s Disease
95. Large-scale visualization of α-synuclein oligomers in Parkinson’s disease brain tissue
    Rebecca Andrews, Bin Fu, Christina E. Toomey, Jonathan C. Breiter, Joanne Lachica, Joseph S. Beckwith, Ru Tian, Emma E. Brock, Lisa-Maria Needham, Gregory J. Chant et al. · 2025 · Nature Biomedical Engineering
96. Evidence Supports PA Prescription for Parkinson’s Disease: Motor Symptoms and Non-Motor Features: A Scoping Review
    Yi-Chen Cheng, Chun-Hsien Su · 2020 · International Journal of Environmental Research and Public Health
97. Human Brain Disorders: A Review
    Falaq Naz, Yasir Hasan Siddique · 2020 · The Open Biology Journal
98. Video Based Shuffling Step Detection for Parkinsonian Patients Using 3D Convolution
    Xugang Cao, Youze Xue, Jiansheng Chen, Xiaohe Chen, Yu Ma, Chunhua Hu, Huimin Ma, Hongbing Ma · 2021 · IEEE Transactions on Neural Systems and Rehabilitation Engineering
99. BORCS6 is involved in the enlargement of lung lamellar bodies in Lrrk2 knockout mice
    Miho Araki, Kyohei Ito, Sho Takatori · 2021 · Human Molecular Genetics
100. Transcriptional and epigenetic regulation of microglia in maintenance of brain homeostasis and neurodegeneration
     Shashank Kumar Maurya, Suchi Gupta, Rajnikant Mishra · 2023 · Frontiers in Molecular Neuroscience